ANI Pharmaceuticals Launches Generic Cymbalta

07:32 AM EDT, 10/19/2026 (MT Newswires) -- ANI Pharmaceuticals (ANIP) launched generic duloxetine delayed-release capsules in 20 mg, 30 mg and 60 mg, offering an alternative to Eli Lilly's (LLY) Cymbalta, the drugmaker said Monday. The launch expands access to a widely used treatment in a market with limited competition, ANI said. US annual sales of duloxetine delayed-release capsules, a treatment for major depressive disorder in adults, reached about $247 million, based on IQVIA data for the 12 months ended August, ANI said.